ANALYSIS OF UNFAVORABLE PROGNOSTIC FACTORS IN PATIENTS WHO RECEIVED HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL HEMOPOIETIC STEM CELLS TRANSPLANTATION FOR RELAPSES AND RESISTANT FORMS OF HODGKIN’’S LYMPHOMA. Вопр. онкол. [Internet]. 2018 Mar. 1 [cited 2026 Oct. 14];64(3):414-8. Available from: https://voprosyonkologii.ru/index.php/journal/article/view/858